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Bile salt-stimulated lipase is a milk enzyme unique to the higher primates. Its molecular and kinetic 
characteristics differ greatly from other lipolytic enzymes; e.g., pancreatic lipase and lipoprotein lipase. 
It has a much higher app. M,, 310000 on gel filtration and 100000 after denaturation. It requires primary 
bile salts for optimal activity and bile salts also protect he enzyme from proteolytic and heat inactivation. 
It may, due to its low substrate specificity, contribute to the utilization of a variety of milk lipids. Since 
it lacks positional specificity, digestion of milk triglycerides should he complete, which may explain why 
fat absorption is more efficient in breast-fed than in formula-fed infants. 
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1. INTRODUCTION 
Every animal species has a unique composition 
of its own milk. This probably reflects differences 
in various needs of their respective offspring. One 
example of this is the bile salt-stimulated lipase 
(BSSL). This enzyme is present in milk only from 
the highest primates. In his original studies, 
Freudenberg [l] investigated milk from several 
species, but found a high, bile salt-stimulated 
lipase activity only in human milk. In a later 
report, he described this enzyme activity also in 
gorilla milk [2]. The situation was further clarified 
when Hemell and Olivecrona demonstrated that 
human milk, unlike milk from most species, con- 
tain not one but two lipases [3]. One lipase activity 
has the same characteristics as that found in milk 
from most mammals and was identified as due to 
a lipoprotein lipase [3]. In addition, human milk 
was found to contain a bile salt-stimulated lipase 
(BSSL) [4]. More recently, we made a thorough 
search for a bile salt-stimulated lipase in milk from 
Rhesus monkeys, but found no evidence for this 
lipase or a protein related to it [5]. Thus, it was 
concluded that BSSL as a milk enzyme, has ap- 
peared late in evolution. It has, however, been 
Lipid digestion Newborn infant 
demonstrated that the milk enzyme is closely 
related to the pancreatic non-specific lipase. The 
fact that antibodies raised against pure BSSL from 
milk react with immunochemical identity with a 
pancreatic protein was the first indication of such 
a pancreatic counterpart [5]. Further studies 
together with Lombard0 and Guy led to the iden- 
tification of this protein as the non-specific lipase 
(also called the carboxyl ester hydrolase) [6]. 
Direct comparison of the enzymes from milk and 
human pancreas revealed that they are in- 
distinguishable in kinetic and immunochemical 
properties as well as in amino acid composition [a]. s 
However, the lipase from milk has a slightly slower 
mobility on electrophoreses in dodecyl sulphate, 
indicating a larger molecular size. Whether this 
difference is in the primary gene product or in its 
processing is not yet known. Although BSSL is 
relatively new as a milk protein its counterpart is 
phylogenetically old as a pancreatic secretory pro- 
tein. A lipase activity stimulated by bile salts is pre- 
sent in shark pancreas whereas the colipase- 
dependent lipase is absent [7]. In the rat, which is 
devoid of bile salt-stimulated lipase activity in 
milk, the pancreatic counterpart, carboxyl ester 
hydrolase, dominates over the colipase-dependent 
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pancreatic lipase as long as the offspring suckles 
[S]. Thus, as long as milk is the main food carboxyl 
ester hydrolase is the essential enzyme for lipid 
digestion. In the newborn infant pancreatic iipase 
activities are low compared with adults f9]. 
Estimation of enzyme activities in duodenal con- 
tents after meals with raw human milk has 
demonstrated that 2/3rds of the non-specific lipase 
activity in duodenal contents originates in milk 
IlW 
2. PURIFICATION AND MOLECULAR 
CHARACTERISTICS 
BSSL can be purified from human milk by se- 
quential chromatographies on heparin immobiliz- 
ed on Sepharose and on Affi-Gel blue [ 111. An 
alternative method based on chromatography on 
taurocholate immobilized on Sepharose has also 
been published [12]. The enzyme is a single-chain 
glycoprotein with a p1 of about 4. The apparent Iw, 
is - 1OOOOO asdetermined by SDS-polyacrylamide 
gel electrophoresis (fig.1). On gel filtration the 
pure enzyme protein elutes at a volume correspon- 
ding to an MI of 310000 (fig.2). The reason for this 
behaviour is unknown. There are at least two 
possibi~ties. Studies done on carboxyl ester 
hydrolase from human pancreas indicate that this 
enzyme has an ellipsoid shape 1151, which could 
result in an abnormal gel filtration behaviour , This 
might be the explanation also for the milk enzyme. 
However, there is also a possibihty that BSSL 
forms aggregates. The fact that the enzyme peak 
(fig.2) is not symmetrical may speak in favour of 
that. At any rate, compared with other lipolytic en- 
zymes (i.e., colipase-dependent pancreatic lipase 
and lipoprotein lipase), BSSL is a much larger 
molecule. 
The amino acid composition of BSSL shows a 
high percentage of acidic residues reflecting the 
comparatively low p1. An unusual feature is that 
proline constitutes more than every tenth residue 
[ll]. The N-terminal residue is alanine. 
In contrast to pancreatic lipase but similar to 
ac~ylcholine esterase BSSL is completely i~ibited 
by eserine [lo]. It is also inhibited by low concen- 
trations of organophosphates such as diisopropyl- 
fluorophosphate [161. In the experiments hown in 
fig.3, the molar ratio between inhibitor and en- 
zyme was 0.75-0.85 in the peak fractions. The 
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Fig. 1. Sodium dodecyl sulphate-polya~~l~ide gel 
electrophoresis of bile salt-stimulated lipase; 25 psg 
purified [ll] enzyme was subjected to electrophoresis 
according to Weber and Osborn [13]. Protein was 
stained with Coomassie brilliant blue as in [14]. 
Pharmacia low-molecular weight calibration kit 
(Ph~a~a Fine Chemicals, Uppsala) was used for 
determination of MI. The cathode is at the top of the 
photo. 
deviation from an equimolar ratio could be ex- 
plained by a minor fraction of inactive enzyme in 
the purified enzyme predation. This is supported 
by the fact that heat-inactivated BSSL coelutes 
with active enzyme on a heparin-Sepharose col- 
umn but does not bind diisopropylfluorophos- 
phate (not shown). These data suggest hat the ac- 
tive site of BSSL contains a serine residue essential 
for catalysis. This is similar to acetylcholine 
esterase and many proteases [18] but different 
from lipoprotein lipase and colipase-dependent 
pancreatic lipase which do not show the same in- 
hibition by organophosphates. 
3. INTERACTION WITH BILE SALTS 
One of the more interesting characteristics of 
BSSL concerns its interaction with bile salts. BSSL 
is active against certain substrates (e.g., tributyrin 
and pnitrophenyl acetate), in the absence of bile 
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Fig.2. Gel filtration of bile salt-stimulated lipase. 
Purified bile salt-stimulated lipase (0.5 mg) was 
dissolved in 0.05 M Tris-HCl buffer (pH 7.5), 0.25 M 
NaCl and applied to a column (1.0 x 110 cm) of 
Sephacryl S-300 equilibrated in the same buffer. The 
flow rate was 12 ml/h. Aliquots of the fractions were 
assayed for lipase activity with an emulsion of long- 
chain triglyceride as substrate as described in [l 11. One 
unit (LJ) is defined as the amount of enzyme that releases 
1 pmol fatty acid/mm. The app. M, of the lipase was 
determined (inset), the void volume ( VO) was determined 
by chromatography of blue dextran. The standard 
proteins used were ovalbumin, bovine serum albumin, 
aldolase and thyroglobulin (Sigma, St Louis MO). 
About 5 mg of each protein was run individually and the 
elution volume (V,) was determined. The arrow indicates 
the elution volume of BSSL. 
salts, but the activity is enhanced by bile salts. The 
bile salt requirement is absolute for activity when 
long-chain triglyceride is the substrate and only the 
primary bile salts, i.e., those containing a 7a- 
hydroxyl group are effective [4]. However, bile 
salts may have effects not only on the enzyme but 
also on the substrate. This complexity is shown in 
fig.4. Taurocholate at 2 or 4 mM gave in this 
system very slow hydrolysis of a long-chain 
triglyceride emulsion. If deoxycholate, which does 
not have the 7cu-hydroxyl group and therefore in 
itself cannot activate the enzyme, was included, a 
many-fold increase in the rate of triglyceride 
hydrolysis was observed. In other words, the 
simultaneous presence of deoxycholate lowered the 
molar requirement of taurocholate. It is evident 
that taurocholate can interact directly with the en- 
zyme protein since BSSL binds to cholate im- 
mobilized on Sepharose [12,16]. The enzyme can 
only be eluted with primary (taurocholate) but not 
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Fig.3. Binding of diisopropylfluorophosphate to bile 
salt-stimulated lipase. Purified BSSL (0.2 mg) was in- 
cubated with an excess radiolabelled diisopropylfluoro- 
phosphate (DFP) (Radiochemical Centre, Amersham) 
for 30 min at 30°C in 5 mM veronal buffer (pH 7.4). 
The mixture was applied to a column of heparin-Se- 
pharose [17], about 2 ml settled gel. The column was 
washed with 6 ml of 5 mM Verona1 @H 7.4), 0.05 M 
NaCl and then eluted with 1.0 M NaCl in the same 
buffer. Each fraction contained 1 ml. Radioactivity was 
determined on aliquots of each fraction. No lipase 
activity could be determined in any fraction. 
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Fig.4. Effect of different bile salts on the activity of bile 
salt-stimulated lipase. The activity of BSSL against long- 
chain triglyceride was determined [1 l] in the presence of 
sodium taurocholate (NaTC) and sodium tauro- 
deoxycholate (NaTDC) as indicated. 
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Fig.5. Protective effect of bile salts on tryptic 
inactivation of bile salt-stimulated lipase. Purified BSSL 
was mixed with trypsin (Sigma, St Louis MO) in a molar 
ratio of 10 mol trypsin/mol BSSL. Incubations were 
carried out in 0.05 M Tris-HCl (pH 7.5) in the presence 
(0) or absence (A) of 5 mM sodium taurocholate. BSSL 
was also incubated in the absence of trypsin as a control 
(0). Incubations were at 37°C and at times indicated 
aliquots were withdrawn and assayed for BSSL activity 
[l 11. The activity is expressed as pmol fatty acid 
released/ml incubation mixture. 
with secondary (deoxycholate) bile salt. Thus, bin- 
ding of bile salt to the enzyme shows the same 
specificity as does activation of enzyme activity. 
Bile salt not only has effects on the catalytical 
ability of the enzyme but also on its stability. In the 
absence of bile salt BSSL is inactivated at >5O”C 
[19]. In the presence of bile salt the enzyme is pro- 
tected against such heat inactivation. To have a 
function in duodenal fat digestion it is of course 
essential that BSSL is not degraded and inactivated 
by intestinal proteolytic enzymes. Fig.5 shows an 
experiment where BSSL was mixed with an excess 
of trypsin (10 mol/mol) in the presence or absence 
of 5 mM taurocholate. In the absence of bile salt 
the activity decreased and after 2 h of incubation 
only about 5% remained, whereas if bile salt was 
included no activity was lost during the incubation 
period. Thus, bile salts protect BSSL also from 
proteolytic degradation which allows the enzyme 
to be fully active in the duodenum of the newborn. 
4. SUBSTRATE SPECIFICITY AND 
PHYSIOLOGICAL ROLE 
BSSL is a non-specific lipase regarding the 
chemical structure of the substrate as well as the 
physical state (table 1). It hydrolyzes short- and 
long-chain triglycerides, diglycerides, monoglycer- 
ides, cholesteryl esters, retinol esters and p-nitro- 
phenyl esters. It also catalyzes synthesis of choles- 
teryl esters. There is no great difference in enzyme 
activity against emulsified, micellar or soluble 
substrates. Thus, the enzyme is able to carry out 
complete fat digestion and, after activation by bile 
salts in duodenal contents, it can supplement low 
endogenous colipase-dependent pancreatic lipase 
and carboxyl ester hydrolase concentrations and 
contribute to an efficient hydrolysis of a variety of 
milk lipids. It can, however, also serve as a com- 
plement to the colipase-dependent pancreatic 
lipase. Due to its positional specificity the latter en- 
zyme hydrolyzes each triglyceride molecule to two 
free fatty acids and one 2-monoglyceride [20]. It 
can also induce acylation forming di- and trigly- 
ceride from fatty acid and monoglyceride [21]. 
Thus, unless monoglycerides are removed the 
Table 1 
Substrate specificity of the bile salt-stimulated lipase 
Substrate 
Chemical structure Physical state Spec. 
acka 
Trioleate Emulsion 5ob 
sn-l(3)monooleate Micellar solution 21b 
sn-Zmonooleate Micellar solution 16b 
Cholesteryl ester Micellar solution 0.5b 
Cholesterol + fatty acid Mice&u solution 2’ 
Retional palmitate Emulsion 6-8b 
pNitropheny1 acetate Aqueous olution 30* 
a Enzyme activities were determined as previously 
described: triglyceride hydrlysis [l 11; monoglyceride 
hydrolysis 1241; cholesteryl ester hydrolysis and syn- 
thesis [6]; retinol ester hydrolysis [lo]; and p-nitro- 
phenyl acetate hydrolysis [lo] 
b Expressed as rmol fatty acid released. min-’ . mg 
protein-’ 
’ Expressed as ,umol golesteryl ester formed. min-’ . mg 
protein-’ 
* Expressed as pmol p-nitrophenol released. min-’ . mg 
protein-’ 
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lipase reaction will stop when equilibrium concen- 
tration are formed. Recently, we have shown that 
BSSL can enhance the forward reaction in trigly- 
ceride hydrolysis while hydrolysing the 2-mono- 
glyceride to glycerol and fatty acid [20]. Therefore, 
BSSL can drive intraluminal lipolysis towards 
completion. It is reasonable to assume that this will 
improve the overall process of fat absorption [22] 
although it is not yet clear exactly how this is ac- 
complished. In support of this point is a report 
that fat absorption in preterm infants was about 
l/3 lower from pasteurized compared with raw 
human milk (pasteurization completely inactivates 
BSSL) [23]. 
5. CONCLUSIONS 
Human milk, in contrast to milk from most 
other species, contains a lipase stimulated by bile 
salts. This lipase is in many respects different from 
other well studied lipolytic enzymes; i.e., lipopro- 
tein lipase and pancreatic colipase-dependent 
lipase. The apparent MI is much higher. In an ac- 
tive state (e.g., during gel filtration) the A4, was 
about 3 10000. BSSL is inhibited by low concentra- 
tions of typical serine-hydrolase inhibitors sug- 
gesting a serine residue in its active site. It requires 
primary bile salts for optimal activity. Bile salts 
also protect the enzyme from inactivation caused 
by heat or proteolysis. The enzyme protein in- 
teracts directly with primary bile salts although the 
stoichiometry is not established. BSSL is fully ac- 
tive in the intestine of the breast-fed newborn. Due 
to its low substrate specificity it can be of great 
significance for the utilization of a variety of milk 
lipids. Furthermore, it has no positional specificity 
and therefore it may confer a last step to trigly- 
ceride hydrolysis in breast-fed infants. This may be 
the explanation of why absorption of fat from 
human milk is superior to that from most artificial 
formulae. 
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